CD4 T-cell function assay using Cylex ImmuKnow and lymphocyte subset recovery following allogeneic hematopoietic stem cell transplantation

Transplant Immunology

Volumn 33, Issue 2, 2015, Pages 78-83

  Jo, Yongjun ^a   Lim, Jihyang ^a   Kim, Yonggoo ^a   Han, Kyungja ^a   Min, Woo Sung ^a   Oh, Eun Jee ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Acute graft versus host disease; Allogeneic hematopoietic stem cell transplantation; CD4; Immune function

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALLOANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE CELL FUNCTION ASSAY; INFECTION; LEUKOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PATIENT MONITORING; PRIORITY JOURNAL; ADOLESCENT; AGED; CELL CULTURE; CHILD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOASSAY; IMMUNOLOGY; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOASSAY; INFECTION; ISOANTIGENS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84943623133     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2015.09.001     Document Type: Article

References (21)

1. Busca A., Lovisone E., Aliberti S., Locatelli F., Serra A., Scaravaglio P., et al. Immune reconstitution and early infectious complications following nonmyeloablative hematopoietic stem cell transplantation. Hematology 2003, 8:303-311.
2. Gesundheit B., Budowski E., Israeli M., Shapira M.Y., Resnick I.B., Bringer R., et al. Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT. Bone Marrow Transplant. 2010, 45:527-533.
3. Berger M., Figari O., Bruno B., Raiola A., Dominietto A., Fiorone M., et al. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Bone Marrow Transplant. 2008, 41:55-62.
4. Kahng J., Yahng S.A., Lee J.W., Kim Y., Kim M., Oh E.J., et al. Novel markers of early neutrophilic and monocytic engraftment after hematopoietic stem cell transplantation. Ann. Lab. Med. 2014, 34:92-97.
5. Heining C., Spyridonidis A., Bernhardt E., Schulte-Mönting J., Behringer D., Grüllich C., et al. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplant. 2007, 39:613-622.
6. Kowalski R.J., Post D.R., Mannon R.B., Sebastian A., Wright H.I., Sigle G., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006, 82:663-668.
7. Sageshima J., Ciancio G., Chen L., Dohi T., El-Hinnawi A., Paloyo S., et al. Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy. Transpl. Immunol. 2014, 30:88-92.
8. Manga K., Serban G., Schwartz J., Slotky R., Patel N., Fan J., et al. Increased adenosine triphosphate production by peripheral blood CD4+ cells in patients with hematologic malignancies treated with stem cell mobilization agents. Hum. Immunol. 2010, 71:652-658.
9. Israeli M., Klein T., Herscovici C., Ram R., Shpilberg O., Sredni B., et al. Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay. Clin. Exp. Immunol. 2013, 172:475-482.
10. Martínez-Flores J.A., Serrano M., Morales P., Paz-Artal E., Morales J.M., Serrano A. Comparison of several functional methods to evaluate the immune response on stable kidney transplant patients. J. Immunol. Methods 2014, 403:62-65.
11. Serban G., Whittaker V., Fan J., Liu Z., Manga K., Khan M., et al. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy. Hum. Immunol. 2009, 70:882-890.
12. Li R.D., Sun Z., Dong J.Y., Yin H., Guo W.Y., Fu Z.R., et al. A quantitative assessment model of T-cell immune function for predicting risks of infection and rejection during the early stage after liver transplantation. Clin. Transpl. 2013, 27:666-672.
13. Yoon J.H., Kim H.J., Jeon Y.W., Lee S.E., Cho B.S., Eom K.S., et al. Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations. Genes Chromosom. Cancer 2015, 54:489-499. 10.1002/gcc.22260.
14. Lee S.E., Kim Y.J., Yahng S.A., Cho B.S., Eom K.S., Lee S., et al. Survival benefits from reduced-intensity conditioning in allogeneic stem cell transplantation for young lower-risk MDS patients without significant comorbidities. Eur. J. Haematol. 2011, 87:510-520.
15. Yoon J.H., Jeon Y.W., Lee S.E., Cho B.S., Eom K.S., Kim Y.J., et al. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas. Hematol. Oncol. 2015, 10.1002/hon.2201.
16. Bacigalupo A., Ballen K., Rizzo D., Giralt S., Lazarus H., Ho V., et al. Defining the intensity of conditioning regimens: working definitions. Biol. Blood Marrow Transplant. 2009, 15:1628-1633.
17. Israeli M., Yussim A., Mor E., Sredni B., Klein T. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform. Transpl. Immunol. 2007, 18:7-12.
18. Huskey J., Gralla J., Wiseman A.C. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. Clin. J. Am. Soc. Nephrol. 2011, 6:423-429.
19. Dokhelar M.C., Wiels J., Lipinski M., Tetaud C., Devergie A., Gluckman E., et al. Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease. Transplantation 1981, 31:61-65.
20. Moretta A., Maccario R., Fagioli F., Giraldi E., Busca A., Montagna D., et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp. Hematol. 2001, 29:371-379.
21. Peggs K.S. Immune reconstitution following stem cell transplantation. Leuk. Lymphoma 2004, 45:1093-1101.